45 CFR § 162.2002

45 CFR · Public Welfare

§ 162.2002 — Standards for health care claims attachments transaction.

45 CFR § 162.2002

TitleTitle 45: Public Welfare PartPart 162: Administrative Requirements

SourceeCFR (current through May 26, 2026)

This text of 45 C.F.R. § 162.2002 (Standards for health care claims attachments transaction.) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

45 C.F.R. § 162.2002 (2026).

Text

§ 162.2002 Standards for health care claims attachments transaction. The Secretary adopts the following standards for the period on and after May 26, 2028:

(a)For transmissions described in § 162.2001, HL7 CDA Release 2: Attachment Implementation Guide: Exchange of C-CDA Based Documents, Release 2—US Realm, Version 2.1.0.1 September 2023 (incorporated by reference, see § 162.920).

(b)For transmissions described in § 162.2001(a)—

(1)HL7 Implementation Guide for CDA Release 2: Consolidated CDA Templates for Clinical Notes (US Realm) Draft Standard for Trial Use Release 2.1, Volume One—Introductory Material, August 2015 with 2019 June Errata (incorporated by reference, see § 162.920)

(2)HL7 Implementation Guide for CDA Release 2: Consolidated CDA Templates for Clinical Notes (US Realm

Free access — add to your briefcase to read the full text and ask questions with AI

§ 162.2002 Standards for health care claims attachments transaction.

The Secretary adopts the following standards for the period on and after May 26, 2028:

(a) For transmissions described in § 162.2001, HL7 CDA Release 2: Attachment Implementation Guide: Exchange of C-CDA Based Documents, Release 2—US Realm, Version 2.1.0.1 September 2023 (incorporated by reference, see § 162.920).

(b) For transmissions described in § 162.2001(a)—

(1) HL7 Implementation Guide for CDA Release 2: Consolidated CDA Templates for Clinical Notes (US Realm) Draft Standard for Trial Use Release 2.1, Volume One—Introductory Material, August 2015 with 2019 June Errata (incorporated by reference, see § 162.920)

(2) HL7 Implementation Guide for CDA Release 2: Consolidated CDA Templates for Clinical Notes (US Realm) Draft Standard for Trial Use Release 2.1, Volume Two—Templates and Supporting Material, June 2019 (incorporated by reference, see § 162.920).

(c) For transmissions described in § 162.2001(a), the ASC X12N/06020X314—Additional Information to Support a Health Care Claim or Encounter (275) (incorporated by reference, see § 162.920).

(d) For transmissions described in section 162.2001(b) that pertain to § 162.2001(a) transmissions, the ASC X12N/006020X313—Health Care Claim Request for Additional Information (277) (incorporated by reference, see § 162.920).

(e) For transmissions described in § 162.2001(a), where a health care provider uses an electronic signature, the HL7 Implementation Guide for CDA Release 2: Digital Signatures and Delegation of Rights, Release 1, Draft Standard for Trial Use, October 2014 (incorporated by reference, see § 162.920).